Overseas Pharma Private Limited

Overseas Pharma Private Limited - pharma in Bangalore, Karnataka, India. FY 2026 financials & compliance.
CIN U24119KA1959PTC001361 Incorporated 18 August 1959 ROC Bangalore HQ Bangalore, Karnataka, India
Active Private Limited Company pharma MSME · Small
Data last updated
Revenue · FY 2025
₹25.6 Cr
▼ 18% YoY
Net profit · FY 2025
₹72.16 Lakh
Net margin 2.8%
EBITDA · FY 2025
₹88.59 Lakh
EBITDA margin 3.5%
Authorised capital
₹25 Lakh
Registered with MCA
Paid-up capital
₹25 Lakh
Issued & subscribed
Open charges
₹5.17 Cr
Secured borrowings
Company age
67 yrs
Est. 1959
Employees · EPFO
9
Provident fund records

About Overseas Pharma Private Limited

Data last updated:

Overseas Pharma Private Limited is a private limited company based in Bangalore, Karnataka, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 18 August 1959 and has been in existence for over 67 years.

The company is registered with the Registrar of Companies (ROC), Bangalore, under CIN U24119KA1959PTC001361. Its GSTIN is 29AAACO1660R1ZX (Karnataka).

The company has an authorised share capital of ₹25 Lakh and a paid-up capital of ₹25 Lakh. It is led by directors including Nerendranath Venkatachala and Manjula Krishnappa.

Its last annual general meeting (AGM) was held on 29 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at No 941 First Floor 21st Main 22nd Cross Banashanakari II Stage, Bangalore, Karnataka, India – 560070.

As per the financials filed for FY 2025, the company reported a revenue of ₹25.6 Cr, a decline of 18% compared to the previous year. For the same year it recorded a net profit of ₹72.16 Lakh (net margin 2.8%) and EBITDA of ₹88.59 Lakh (EBITDA margin 3.5%). Revenue has grown at a compounded annual rate (CAGR) of 4% over three years and 70% over five years.

The company has about 9 employees on its provident fund (EPFO) records.

As per MCA filings, the company has open charges of ₹5.17 Cr on record. Court records list 14 cases involving the company, including 7 filed by the company and 7 filed against it; 3 cases are pending.

Overseas Pharma Private Limited is registered as a small enterprise under the Udyam registration framework (Reg. No. UDYAM-KR-03-0049539). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website overseaspharma.in.

Company details

CIN U24119KA1959PTC001361
Registration Number 001361
Incorporation Date 18 August 1959
ROC Bangalore
Listing Status Unlisted
Company Status Active
Date of Last AGM 29 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
MSME Classification Small
Udyam Registration UDYAM-KR-03-0049539
Key People
Nerendranath Venkatachala Director Manjula Krishnappa Director Thimmaiah Thimme Gowda Director

Recognitions & Rankings of Overseas Pharma

MSME (Udyam registered) Ministry of MSME
Category
Small (2024-25)
Udyam number
UDYAM-KR-03-0049539

Contact details

Overseas Pharma Private Limited's registered office is in Bangalore, Karnataka. Its website is overseaspharma.in. Its e-mail address and telephone number are in the company report.

  • Email
  • Telephone
  • Website
    overseaspharma.in
  • Registered Address
    No 941 First Floor 21st Main 22nd Cross Banashanakari II Stage, Bangalore, Karnataka, India – 560070
  • Industry
    Pharma, Drug Formulation & Development

To see the full contact details of Overseas Pharma Private Limited, buy the company report.

Comprehensive company report
Overseas Pharma Private Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Business activity

The main business activity of Overseas Pharma is manufacturing. In detail, this covers manufacture of food products.

Main activity group codeMain activityBusiness activity codeBusiness activityShare of turnover
CManufacturing10Manufacture of food products

To see the full business activity and turnover split of Overseas Pharma Private Limited, buy the company report.

Financials of Overseas Pharma Private Limited

FY 2025 filings available

Overseas Pharma Private Limited reported revenue of ₹25.6 Cr (down 18% YoY) for FY 2025.

Revenue · FY 2025
₹25.6 Cr ▼ 18%
Net profit · FY 2025
₹72.16 Lakh margin 2.8%
EBITDA · FY 2025
₹88.59 Lakh margin 3.5%

Compounded Annual Growth Rate (CAGR)

Revenue CAGR growth
1 year
▼ 18%
3 years · compounded
▲ 4%
5 years · compounded
▲ 70%
EBITDA CAGR growth
1 year
▼ 10%
3 years · compounded
▼ 27%
5 years · compounded
▲ 89%

Revenue fell 18% in the latest year, but over five years it has grown at a compounded annual rate (CAGR) of 70%. EBITDA fell 10% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.

Financial Statement Summary

MetricsFY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profit and Loss Statement
Revenue from Operations
Other Income
Total Revenue
Cost of Materials Consumed
Employee Benefit Expense
Finance Costs
Depreciation and Amortisation
Other Expenses
Total Expenses
EBITDA₹88.59 Lakh
Profit Before Tax
Tax Expense
Net Profit (PAT)₹72.16 Lakh
Balance Sheet
Share Capital
Reserves and Surplus
Net Worth (Total Equity)
Long-term Borrowings
Short-term Borrowings
Trade Payables
Total Liabilities
Fixed Assets
Investments
Inventories
Trade Receivables
Cash and Bank Balance
Total Assets

Financial Ratios

MetricsFY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profitability
EBITDA Margin3.5%
Net Profit Margin2.8%
Return on Equity (ROE)
Return on Capital Employed (ROCE)
Return on Assets (ROA)
Liquidity and Debt
Current Ratio
Quick Ratio
Debt-to-Equity Ratio
Interest Coverage Ratio
Efficiency and Growth
Asset Turnover
Receivable Days
Payable Days
Inventory Days
Revenue Growth
Net Profit Growth

To see the full financial statements and ratios of Overseas Pharma Private Limited, buy the company report.

Board of directors of Overseas Pharma Private Limited

Overseas Pharma has 3 current directors and 8 former directors. Current directors are listed first, with their designation and appointment date.

Current Directors
NameDesignationAppointment DateTenureStatus
Nerendranath Venkatachala
Also directs: Vertexhealth Comprehensive Health Services LLP, Hindustan Pharma Distributors Private Limited, Dr. Ramesh Cardiac and Multispeciality Hospital Private Limited and 2 more
Director16 Jan 20179 Years 9 MonthsCurrent
Manjula KrishnappaDirector16 Jan 20179 Years 9 MonthsCurrent
Thimmaiah Thimme Gowda
Also directs: Megha Autoelectric Private Limited, Megha Landmark Estates Private Limited, Megha Travel Solutions Private Limited
Director05 Jan 20179 Years 9 MonthsCurrent
View all directors

Auditor

Overseas Pharma Private Limited is audited by K N Sudhakara Reddy & Co for the financial year 2023.

Auditor firmFinancial yearFirm registration number
K N Sudhakara Reddy & CoFY 2023204091

Shareholding

The shareholding of Overseas Pharma Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.

Shareholder categoryFY 2023FY 2022FY 2021FY 2020FY 2019
Promoters
Domestic institutional investors (DII)
Foreign institutional investors (FII)
Public
Others

To see the full shareholding pattern of Overseas Pharma Private Limited, buy the company report.

Charges & borrowings

Open charges
₹5.17 Cr
Satisfied charges
None
Breakdown by lending institutions
Others₹4.95 Cr
Canara Bank₹0.22 Cr
Latest charge details
DateCharge IDLenderAmountStatusModified or satisfied on
20 May 2025101098190Others₹4.95 CrOpen
15 Feb 2021100426825Canara Bank₹22 LakhOpen

Total charge records: 2 View all charges

MSME payment delays

No delayed payments to MSME suppliers are on our record for Overseas Pharma Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.

Employees & EPFO

Overseas Pharma Private Limited has a workforce of 9 employees on its EPFO records as of Apr 06, 2024, across 1 active EPFO establishment.

Employee count
9
Active EPFO establishments
1
Employee growth
-10%

GST

Overseas Pharma has 1 GST registration: 1 active.

Total GSTINs
1
Active
1
GSTINStateStatusRegistered on
29AAACO1660R1ZXKarnatakaActive01 Jul 2017

To see the full GST registrations and return filing status of Overseas Pharma Private Limited, buy the company report.

Recent activity

Overseas Pharma Private Limited has 12 board changes on record since 2010: 4 appointments and 8 cessations. The latest: Manjula Krishnappa ceased to be Additional Director on 29 Sep 2017.

AGM
Overseas Pharma Private Limited last Annual general meeting of members was held on 29 Sep 2025 as per latest MCA records.
Charges
A charge with Others amounted to Rs. 495.00 Lakh with Charge ID 101098190 was registered on 20 May 2025.
Filing
Overseas Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Bangalore.
Charges
A charge with Canara Bank amounted to Rs. 22.00 Lakh with Charge ID 100426825 was registered on 15 Feb 2021.
Ceased
Manjula Krishnappa ceased to be Additional Director.
Ceased
Nerendranath Venkatachala ceased to be Additional Director.
Ceased
Thimmaiah Thimme Gowda ceased to be Additional Director.
Ceased
Untagodu Shamanna Pavithra ceased to be Additional Director.
Ceased
Katapadi Shobha Shenoy ceased to be Whole-Time Director.
Appointed
Manjula Krishnappa was appointed as Director.
Ceased
Nagar Shanthi Nayak ceased to be Managing Director.
Appointed
Nerendranath Venkatachala was appointed as Director.

5 earlier events are in the company report.

Frequently asked questions

Overseas Pharma is an active private limited company based in Bangalore, Karnataka, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 18 August 1959 (67+ years old) and is registered under CIN U24119KA1959PTC001361.

Overseas Pharma has 3 current directors:

The latest financial statements of Overseas Pharma on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 29 September 2025. Year-wise statements from 2015 are in the company report.

The GSTIN of Overseas Pharma is 29AAACO1660R1ZX, registered in Karnataka.

The CIN (Corporate Identification Number) of Overseas Pharma is U24119KA1959PTC001361. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Overseas Pharma has 14 court cases on record: 7 filed by the company and 7 filed against it. 3 are pending. Most are in the high courts.

Overseas Pharma was incorporated on 18 August 1959, making it 67+ years old. It is registered with the Registrar of Companies, Bangalore.

Manjula Krishnappa ceased to be Additional Director on 29 Sep 2017. Nerendranath Venkatachala ceased to be Additional Director on 29 Sep 2017. Thimmaiah Thimme Gowda ceased to be Additional Director on 29 Sep 2017. Overseas Pharma has 12 board changes on record in total.

Yes, Overseas Pharma is registered as a small enterprise under Udyam registration (number: UDYAM-KR-03-0049539).

Overseas Pharma can be reached through the website overseaspharma.in. Its registered office is in Bangalore, Karnataka, India.